Intellectual Property India Publishes Patent Application for 'A Novel Heterocyclic Compound Thiazol- 5-Bromo-3'-(2-Oxo-2h- Chromen-3-Yl) Spiro[Indoline-3,2'- Thiazolidine]-2,4'-Dione & Method Of Synthesis Thereof' Filed by Dr. Krishna Srivastava; Dr. Nitin Srivastava; Dr. Rishi Kumar Vishnoi; Dr. Braj Kishore Rathour; Dr. Soniya Singh; and Dr. Manoj Kumar Verma

MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202411003333 A) filed by Dr. Krishna Srivastava; Dr. Nitin Srivastava; Dr. Rishi Kumar Vishnoi; Dr. Braj Kishore Rathour; Dr. Soniya Singh; and Dr. Manoj Kumar Verma, Barabanki, Uttar Pradesh, on Jan. 15, 2024, for 'a novel heterocyclic compound thiazol- 5-bromo-3'-(2-oxo-2h- chromen-3-yl) spiro[indoline-3,2'- thiazolidine]-2,4'-dione & method of synthesis thereof.'

Inventor(s) include Dr. Krishna Srivastava; Dr. Nitin Srivastava; Dr. Rishi Kumar Vishnoi; Dr. Braj Kishore Rathour; Dr. Soniya Singh; and Dr. Manoj Kumar Verma.

The application for the patent was published on July 25, under issue no. 30/2025.

According to the abstract released by the Intellectual Property India: "The invention provides a novel heterocyclic compound thiazol- 5-bromo-3'-(2-oxo-2Hchromen-3-yl) spiro[indoline-3,2'-thiazolidine]-2,4'-dione. The invention also provides a single step, cost-effective and modified method of synthesis for obtaining novel heterocyclic compound thiazol- 5-bromo-3'-(2-oxo-2H- chromen-3-yl) spiro[indoline-3,2'-10 thiazolidine]-2,4'-dione."

Disclaimer: Curated by HT Syndication.